跳至主要内容
临床试验/NL-OMON25843
NL-OMON25843暂停不适用

MRI-Assisted high intensity focused ultrasoundmetastatic Liver Tumor Ablation

niversity Medical Center Utrecht0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
入组人数
10

研究概览

简要总结

For an introduction, please refer to: Wijlemans JW, Bartels LW, Deckers R, Ries M, Mali WP, Moonen CT, Van den Bosch MA. Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) ablation of liver tumours. Cancer Imaging. 2012 Sep 28;12:387-94.

研究设计

研究类型
Interventional

入排标准

入选标准

  • At least 18 years old
  • - Able to give informed consent
  • - One or more metastatic liver tumor(s)
  • - Target tumor is eligible for surgical resection
  • - Sufficient physical condition to undergo general anesthesia or deep sedation
  • - Waist circumference that allows positioning on the HIFU table-top inside the MR bore
  • - Based on a clinically available CT/MRI scan, the liver tumor is potentially accessible for MR-HIFU treatment

排除标准

  • - Contra-indication for MRI scanning
  • - Contra-indication to injection of gadolinium-based contrast agent, including known prior allergic reaction to any contrast-agent, and renal failure (defined as GFR < 30mL/min/1.73m2)
  • - Patients who prefer not to be informed about unexpected MRI findings
  • - Surgical clips or considerable scar tissue in the HIFU beam path
  • - Past or future other loco-regional therapies for the same tumor (that is to be treated with MR-HIFU ablation) until the moment of surgical resection, such as (but not restricted to) RF ablation, microwave ablation, cryoablation, chemo-embolization, radio-embolization, or radiotherapy.

研究者

相似试验